Mr. Alex Yu

Founder and CEO at Veliter

Speaker

Alex Xu, with his extensive background in small molecule drugs and oligonucleotides, has significantly contributed to the field since 2007. His roles have included Senior Scientist and Project Leader at Ariad Pharm. Inc., Qiagen, and Nitto Avecia Inc. Since July 2019, Alex returned to China from Boston to establish Shenzhen Veliter Biotechnology Co., Ltd, Guangdong Veliter Biomedical Technology Co., Ltd, and Hunan Veliter Biomedical Technology Co., Ltd respectively. Alex and his leadership aim to foster game changing nucleic acid drug therapies through strategic partnerships with global gene therapy innovators.